Related references
Note: Only part of the references are listed.Dexmedetomidine-Mediated Prevention of Renal Ischemia-Reperfusion Injury Depends in Part on Cholinergic Anti-Inflammatory Mechanisms
Jianbo Ma et al.
ANESTHESIA AND ANALGESIA (2020)
Impact of Dexmedetomidine on Long-term Outcomes After Noncardiac Surgery in Elderly: 3-Year Follow-up of a Randomized Controlled Trial
Dan-Feng Zhang et al.
ANNALS OF SURGERY (2019)
Dexmedetomidine Prevents Cognitive Decline by Enhancing Resolution of High Mobility Group Box 1 Protein-induced Inflammation through a Vagomimetic Action in Mice
Jun Hu et al.
ANESTHESIOLOGY (2018)
Dexmedetomidine attenuates pancreatic injury and inflammatory response in mice with pancreatitis by possible reduction of NLRP3 activation and up-regulation of NET expression
Yong Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Dexmedetomidine attenuated early brain injury in rats with subarachnoid haemorrhage by suppressing the inflammatory response: The TLR4/NF-κB pathway and the NLRP3 inflammasome may be involved in the mechanism
Dongpei Yin et al.
BRAIN RESEARCH (2018)
Human astrocytes in the diseased brain
Elena Dossi et al.
BRAIN RESEARCH BULLETIN (2018)
Dexmedetomidine promotes liver regeneration in mice after 70% partial hepatectomy by suppressing NLRP3 inflammasome not TLR4/NFκB
Meihong Lv et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome
Pei Jiang et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1β
Paul R. Lee et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Neuroprotection and neurotoxicity in the developing brain: an update on the effects of dexmedetomidine and xenon
Azeem Alam et al.
NEUROTOXICOLOGY AND TERATOLOGY (2017)
Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts
Manmeet K. Mamik et al.
BRAIN (2017)
Lipopolysaccharide-Induced Apoptosis of Astrocytes: Therapeutic Intervention by Minocycline
Arpita Sharma et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
Low-dose Dexmedetomidine Improves Sleep Quality Pattern in Elderly Patients after Noncardiac Surgery in the Intensive Care Unit A Pilot Randomized Controlled Trial
Xin-Hai Wu et al.
ANESTHESIOLOGY (2016)
GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
Lorenzo Sborgi et al.
EMBO JOURNAL (2016)
Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium A Randomized Clinical Trial
Michael C. Reade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Imaging Lymphoid Cell Death In Vivo During Polymicrobial Sepsis
Lin Zou et al.
CRITICAL CARE MEDICINE (2015)
Dexmedetomidine Attenuates Bilirubin-Induced Lung Alveolar Epithelial Cell Death In Vitro and In Vivo
Jian Cui et al.
CRITICAL CARE MEDICINE (2015)
Pyroptotic cell death defends against intracellular pathogens
Ine Jorgensen et al.
IMMUNOLOGICAL REVIEWS (2015)
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi et al.
NATURE (2015)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
1 Dexmedetomidine Attenuates Oxidative Stress Induced Lung Alveolar Epithelial Cell Apoptosis In Vitro
Jian Cui et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Pyroptotic death storms and cytopenia
Ben A. Croker et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Inflammasomes in the CNS
John G. Walsh et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Cell Injury and Repair Resulting from Sleep Loss and Sleep Recovery in Laboratory Rats
Carol A. Everson et al.
SLEEP (2014)
Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells
Silvia Alfonso-Loeches et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Neuroprotective Effects of Dexmedetomidine against Glutamate Agonist-induced Neuronal Cell Death Are Related to Increased Astrocyte Brain-derived Neurotrophic Factor Expression
Vincent Degos et al.
ANESTHESIOLOGY (2013)
On Nontraumatic Brain Injury in Pediatric Critical Illness, Neuropsychologic Short-Term Outcome, Delirium, and Resilience
Jan N. M. Schieveld et al.
CRITICAL CARE MEDICINE (2013)
Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit
Juliana Barr et al.
CRITICAL CARE MEDICINE (2013)
Current trends in inflammatory and immunomodulatory mediators in sepsis
Monowar Aziz et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1
Chuanjiang Huang et al.
PLOS ONE (2013)
Sleep Drives Metabolite Clearance from the Adult Brain
Lulu Xie et al.
SCIENCE (2013)
Extracellular Chromatin Is an Important Mediator of Ischemic Stroke in Mice
Simon F. De Meyer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Histones from Dying Renal Cells Aggravate Kidney Injury via TLR2 and TLR4
Ramanjaneyulu Allam et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Sleep and immune function
Luciana Besedovsky et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2012)
Novel Therapeutic Targets for Sepsis: Regulation of Exaggerated Inflammatory Responses
Akihisa Matsuda et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2012)
Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system
W. Liu et al.
LIFE SCIENCES (2011)
Astrocyte-neuron metabolic relationships: for better and for worse
Igor Allaman et al.
TRENDS IN NEUROSCIENCES (2011)
Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice
Jianteng Gu et al.
CRITICAL CARE (2011)
Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain
R. D. Sanders et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2010)
Characterization of the Postconditioning Effect of Dexmedetomidine in Mouse Organotypic Hippocampal Slice Cultures Exposed to Oxygen and Glucose Deprivation
Souhayl Dahmani et al.
ANESTHESIOLOGY (2010)
Sustained hippocampal IL-1β overexpression impairs contextual and spatial memory in transgenic mice
Amy M. Hein et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Dexmedetomidine Attenuates Isoflurane-induced Neurocognitive Impairment in Neonatal Rats
Robert D. Sanders et al.
ANESTHESIOLOGY (2009)
Microglial Physiology: Unique Stimuli, Specialized Responses
Richard M. Ransohoff et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients A Randomized Trial
Richard R. Riker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
NOS2 Gene Deficiency Protects from Sepsis-Induced Long-Term Cognitive Deficits
Marc Weberpals et al.
JOURNAL OF NEUROSCIENCE (2009)
Extracellular histones are major mediators of death in sepsis
Jun Xu et al.
NATURE MEDICINE (2009)
Sepsis: the dark side of histones
Catherine Chaput et al.
NATURE MEDICINE (2009)
Pyroptosis: host cell death and inflammation
Tessa Bergsbaken et al.
NATURE REVIEWS MICROBIOLOGY (2009)
MECHANISMS OF DISEASE Cell Death
Richard S. Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Sedation improves early outcome in severely septic Sprague Dawley rats
Hong Qiao et al.
CRITICAL CARE (2009)
Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation
Jae Woong Lee et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models
Nishanthan Rajakumaraswamy et al.
NEUROSCIENCE LETTERS (2006)
Dexmedetomidine produces its neuroprotective effect via the α2A-adrenoceptor subtype
DQ Ma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis
WX Huang et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care
RM Venn et al.
BRITISH JOURNAL OF ANAESTHESIA (2002)
Production of IL-1β and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis
BA de Jong et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease:: peripheral inflammation or signals from the brain?
F Licastro et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Share Paper
